Hospital Ruber Internacional
Radioembolization for liver cancer in Spain costs from $24,000 to $33,000. Pricing depends on tumor complexity, number of lobes treated, and the specific hospital facility. People save about 54% compared to the US, where costs average $62,500. The price typically includes PET/CT imaging, Yttrium-90 microspheres, and a short hospital stay.
Bookimed Expert Insight: Spain offers elite oncology care at a fraction of North American prices. Clinica Universidad de Navarra is a standout choice for international patients. It is accredited by Joint Commission International (JCI). It was also named among the World's Best Hospitals by Newsweek. Choosing such a high-volume center ensures access to 440 expert doctors. This provides a balance of clinical excellence and cost efficiency.
| Turkey | Austria | Spain | |
| Radioembolization for liver cancer | from $18,600 | ≈ $35,000 | ≈ $24,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Radioembolization for liver cancer upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Radioembolization for liver cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Radioembolization for liver cancer journey.
Day 1: Arrival
Day 2: Pre-operation
Day 3: Radioembolization
Day 4: Post-operation
Week 1: Rehabilitation
Week 2 to 4: Rehabilitation
Please note that each patient"s journey to recovery may vary depending on their overall health, the size and location of the tumor, and their body"s response to the treatment.
Dr. Jose Ignacio Bilbao is the Head of Vascular and Interventional Radiology at Clinica Universidad de Navarra. He specializes in interventional oncology and lung cancer treatment. Dr. Bilbao works at a hospital ranked among the World's Best Hospitals by Newsweek. The clinic holds JCI accreditation.
Radioembolization is primarily a management tool rather than a guaranteed cure for liver cancer. This targeted therapy delivers high-dose Yttrium-90 radiation directly to tumors to shrink or stabilize them. While it effectively extends life, it usually serves as a bridge to curative surgery or transplant.
Bookimed Expert Insight: Spain represents a unique value proposition where JCI-accredited facilities like Clinica Universidad de Navarra provide advanced oncology care for $24,000 to $33,000. This is significant because the same procedure averages $62,500 in the US. The 54% cost reduction allows patients to access multidisciplinary tumor boards at top-tier centers like Hospital Ruber Internacional without sacrificing clinical technology.
Patient Consensus: Many patients emphasize that Y-90 is a vital tool for staying stable while awaiting a transplant. They often report that achieving cancer-free status requires combining this therapy with other surgical or systemic treatments.
Radioembolization (Y90) is a targeted treatment for liver cancer delivering high-dose radiation through Yttrium-90 microspheres. This minimally invasive interventional radiology procedure blocks tumor blood supply while sparing healthy tissue. It treats primary hepatocellular carcinoma and metastatic colorectal cancer in JCI-accredited Spanish centers.
Bookimed Expert Insight: Spain ranks second globally for radioembolization requests due to high-tier academic centers like Clinica Universidad de Navarra. This facility was Spain's first JCI-accredited hospital and maintains specialized oncology expertise. Choosing these high-volume centers is vital because Y90 is typically limited to 2 sessions per patient.
Patient Consensus: Expect significant fatigue and liver pain during the first week. Patients emphasize that tumor necrosis takes time, so patience is necessary during the 3-month wait for follow-up scans.
Radioembolization for liver cancer in Spain involves delivering radioactive Yttrium-90 (Y-90) beads directly to tumors through a catheter. This minimally invasive approach utilizes the dual blood supply of the liver. It targets tumors via the hepatic artery while protecting healthy tissue supported by the portal vein.
Bookimed Expert Insight: Spain hosts top-tier facilities like Clinica Universidad de Navarra, the first JCI-accredited hospital there. Data shows Spanish oncology centers often combine radioembolization with systemic therapies like lenvatinib. This multimodal approach aims to arrest tumor growth through central necrosis rather than just shrinkage. Patients benefit from experienced teams performing thousands of specialized vascular interventions yearly.
Patient Consensus: Many find the outpatient nature of the procedure surprisingly manageable compared to major surgery. Most experience only mild fatigue or flu-like symptoms for about 1 week after treatment.
Spain hosts premier centers for radioembolization (TARE/SIRT), primarily in Madrid and Pamplona. Leading facilities include Clínica Universidad de Navarra, an ESMO-accredited oncology center, and Hospital Ruber Internacional. These JCI-accredited hospitals utilize multidisciplinary teams of interventional radiologists and nuclear medicine specialists for advanced liver cancer treatment.
Bookimed Expert Insight: Spain ranks 2nd globally for patient requests in our network. This high volume concentrates expert surgeons in specialized hubs like Madrid and Pamplona. Choosing JCI-accredited centers in these cities ensures access to multidisciplinary teams often missing in smaller clinics. Experience counts here as SIRT requires precise coordination between oncology and radiology.
Patient Consensus: Many patients recommend verifying specific eligibility with an oncologist before traveling. Seeking a second opinion is often encouraged for this highly specialized therapy.
Spain offers high-level radioembolization for liver cancer using Yttrium-90 (Y-90) techniques performed in Joint Commission International (JCI)-accredited facilities. Patients access advanced focal treatment strategies that average $24,000 to $33,000, significantly less than the $62,500 typical in the United States.
Bookimed Expert Insight: Spain ranks second globally on Bookimed for complex oncology requests due to institutional expertise. Clinica Universidad de Navarra serves 140,000 patients annually and consistently ranks in Newsweek’s Best World Hospitals. Choosing these high-volume centers ensures access to specialists familiar with various hepatocellular carcinoma protocols.
Patient Consensus: Patients emphasize utilizing Y-90 primarily for tumor stabilization when other therapies fail. Researching hospital-specific outcome reports and finding doctors specializing in neuroendocrine tumor protocols is highly recommended.